Showing results (61-70 of 12,391) with videos related to

Sort By:
Pageof 1,240
European Journal of Cancer (Oxford, England : 1990)|July 27, 2010
Promoter polymorphisms in matrix metallopeptidase 1 and risk of cutaneous melanomaLi-E Wang, Yu-jing Huang, Ming Yin, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2010
Novel mechanism of reducing tumourigenesis: upregulation of the DNA repair enzyme OGG1 by rapamycin-mediated AMPK activation and mTOR inhibitionSamy L Habib, Balakuntalam S Kasinath, Ruth Rector Arya, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2010
A multi-centre Canadian pilot study of metronomic temozolomide combined with radiotherapy for newly diagnosed paediatric brainstem gliomaJulia R Sharp, Eric Bouffet, Diana Stempak, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 2010
Expression of nuclear FIH independently predicts overall survival of clear cell renal cell carcinoma patientsStephanie G C Kroeze, Joost S Vermaat, Aram van Brussel, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 2010
STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signalingZhenlian Wang, Feijun Luo, Lili Li, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 2010
Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatmentJacques Tostain, Guorong Li, Anne Gentil-Perret, et al.
European Journal of Cancer (Oxford, England : 1990)|August 25, 2010
Hospitalisations 1998-2000 in a British Columbia population-based cohort of young cancer survivors: report of the Childhood/Adolescent/Young Adult Cancer Survivors (CAYACS) Research ProgramNicole M E Bradley, Maria F Lorenzi, Zenaida Abanto, et al.
European Journal of Cancer (Oxford, England : 1990)|September 21, 2010
Prognostic factors in women treated for ovarian yolk sac tumour: a retrospective analysis of 84 casesThibault de La Motte Rouge, Patricia Pautier, Annie Rey, et al.
European Journal of Cancer (Oxford, England : 1990)|September 25, 2010
Sorafenib tosylate and paclitaxel induce anti-angiogenic, anti-tumour and anti-resorptive effects in experimental breast cancer bone metastasesMaximilian Merz, Dorde Komljenovic, Stefan Zwick, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2010
Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancerKonstantin J Dedes, Rachael Natrajan, Maryou B Lambros, et al.
Pageof 1,240